Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Bladder cancer".)
International
Canada
●Alberta Health Services (AHS): Clinical practice guideline on muscle-invasive bladder cancer (2021)
●CUA: Best practice report for the diagnosis and management of radiation-induced hemorrhagic cystitis (2019)
●CUA: Guideline on muscle-invasive bladder cancer (2019)
United States
●National Cancer Institute (NCI): Bladder cancer treatment – Health professional version (updated 2021)
●AUA/SUO: Joint guideline for the diagnosis and treatment of non-muscle invasive bladder cancer (2016, amended 2020)
Europe
●European Association of Urology (EAU): Guidelines on muscle-invasive and metastatic bladder cancer (2022)
●EAU: Guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) (2022)
United Kingdom
Japan
●[In English] Japanese Urological Association (JUA): Clinical practice guidelines for bladder cancer, 2019 edition by the revision working position paper (published 2020)
●[In Japanese] JUA: Bladder cancer practice guidelines (2019)
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟